Iterum Therapeutics plc Made Big Gain
Thu, Dec 05, 2019 at 05:30 PM
Iterum Therapeutics plc (ITRM:NASDAQ) rocketted at $3.55, representing a gain of 29.1%. On Wed 04 Dec 19, ITRM:NASDAQ hit a New 2-Week Intraday High of $3.34. The stock got featured on our News Catalysts scanner on Mon 18 Nov 19 at 08:02 AM in the 'BIOTECH' category. From Wed 13 Nov 19, the stock recorded 57.14% Up Days and 60.00% Green Days
About Iterum Therapeutics plc (ITRM:NASDAQ)
Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally.
Top 10 Gainers:
- Aurinia Pharmaceuticals Inc. (AUPH:NASDAQ), 78.78%
- QuickLogic Corporation (QUIK:NASDAQ), 36.08%
- Proteostasis Therapeutics, Inc. (PTI:NASDAQ), 35.36%
- SecureWorks Corp. (SCWX:NASDAQ), 29.45%
- Iterum Therapeutics plc (ITRM:NASDAQ), 29.09%
- Express, Inc. (EXPR:NYSE), 27.88%
- BIO-key International, Inc. (BKYI:NASDAQ), 27.27%
- Duluth Holdings Inc. (DLTH:NASDAQ), 24.58%
- DermTech, Inc. (DMTK:NASDAQ), 24.21%
- Syndax Pharmaceuticals, Inc. (SNDX:NASDAQ), 21.52%